4C Medical

Focus: 4C Medical is a minimally invasive medical device company focused on treating mitral regurgitation, a significant cardiac pathology affecting millions globally. The company is early-stage and pre-revenue, operating from Maple Grove, Minnesota.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About 4C Medical

AI assessmentNot Hiring

No open roles listed right now. Follow 4C Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

AltaValve

Mitral Regurgitation

N/A

Clinical Trials (1)

NCT03997305AltaValve Early Feasibility Study Protocol

N/A

Help build intelligence for 4C Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity at a focused company targeting a large, underserved cardiac market with high unmet need
AltaValve System represents a novel minimally invasive approach to mitral regurgitation, a condition affecting 2-3% of the population
Early-stage environment offers potential for significant equity upside and direct impact on product development trajectory

Watch Out For

No disclosed funding, revenue, or employee count—financial sustainability and runway are undisclosed and potentially constrained
Zero active job openings at time of analysis indicates either very lean operations or early hiring phase with limited immediate opportunity
Pre-revenue status with only 2 clinical trials on record suggests early clinical stage with substantial risk before market validation

Generated by Claude from 4C Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

AltaValve System

Mitral Regurgitation

N/A

Clinical Trials (1)

NCT06465745AltaValve Pivotal Trial

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo